U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181018) titled 'Metabolic Syndrome Among Polish Twins' on Sept. 12.
Brief Summary: Over a 5-year follow-up period, we aim to conduct a study among twins aged 15-44 years from the Polish population with the following objectives:
1. To determine the incidence and risk factors for the development of de novo metabolic dysfunction-associated steatotic liver disease (MASLD), liver fibrosis, or cirrhosis. We also intend to evaluate the progression of hepatic steatosis from early to advanced stages or toward fibrosis/cirrhosis.
2. To determine the prevalence and identify predictive factors for the onset and progression of features, diseases, or complica...